Health-Related Quality-of-Life Analysis of Surufatinib Versus Placebo for Advanced Neuroendocrine Tumors: Pooled Results From Two Phase 3 Studies (SANET-p and SANET-ep)
第一作者单位:[1]Peking Union Med Coll Hosp, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
Bai Chunmei,Xu Jianming,Shen Lin,et al.Health-Related Quality-of-Life Analysis of Surufatinib Versus Placebo for Advanced Neuroendocrine Tumors: Pooled Results From Two Phase 3 Studies (SANET-p and SANET-ep)[J].PANCREAS.2022,51(3):E39-E39.
APA:
Bai, Chunmei,Xu, Jianming,Shen, Lin,Li, Jie,Zhou, Zhiwei...&Su, Weiguo.(2022).Health-Related Quality-of-Life Analysis of Surufatinib Versus Placebo for Advanced Neuroendocrine Tumors: Pooled Results From Two Phase 3 Studies (SANET-p and SANET-ep).PANCREAS,51,(3)
MLA:
Bai, Chunmei,et al."Health-Related Quality-of-Life Analysis of Surufatinib Versus Placebo for Advanced Neuroendocrine Tumors: Pooled Results From Two Phase 3 Studies (SANET-p and SANET-ep)".PANCREAS 51..3(2022):E39-E39